Shares of Synta Pharmaceuticals (Nasdaq:SNTA) were gapping down Friday morning with an open price 14.4% lower than Thursday's closing price. The stock closed at $5.14 yesterday and opened today's trading at $4.40.
NEW YORK ( TheStreet) -- Shares of Synta Pharmaceuticals (Nasdaq: SNTA) were gapping down Friday morning with an open price 14.4% lower than Thursday's closing price. The stock closed at $5.14 Thursday and opened today's trading at $4.40. The average volume for Synta has been 139,700 shares per day over the past 30 days. Synta has a market cap of $239.1 million and is part of the health care sector and drugs industry. Shares are up 10.1% year to date as of the close of trading on Thursday. Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drug candidates for treating severe medical conditions, including cancer and chronic inflammatory diseases. TheStreet Ratings rates Synta as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, disappointing return on equity, weak operating cash flow, deteriorating net income and generally disappointing historical performance in the stock itself. You can view the full Synta Ratings Report. Get more investment ideas from our investment research center. Interested in other stocks that are gapping down? Get free SMS text alerts sent to you when the action happens by texting DOWN to 95370 or select from multiple alert options.